Blood Cancer
Expert Talks Major Advances within the Blood Cancer Space
Now that the CD19-centered CAR T-mobile healing procedures axicabtagene ciloleucel (axis-cel; Yescarta) and tisagenlecleucel (Kymriah) have shown long-lasting responses inside...
Read more
Survival Rate of Blood Cancer Patients
The survival rate of cancer patients has increased over the past few years, and it is even better in the...
Read more
